Inventor
ZOU NING
US19 patents
⚠️ This page may combine multiple inventors who share the name “ZOU NING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
12 patentsUS9328107B2May 3, 2016
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
USRE45336EJan 13, 2015
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
US9012478B2Apr 21, 2015
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC4 citations83
US11098034B2Aug 24, 2021
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations72
US10689372B2Jun 23, 2020
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations72
US10214518B2Feb 26, 2019
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC2 citations72
US9663500B2May 30, 2017
Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC3 citations72
US10793529B2Oct 6, 2020
Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators
ARENA PHARM INC1 citations71
US10668033B2Jun 2, 2020
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC4 citations70
US9987252B2Jun 5, 2018
Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations62
US10138210B2Nov 27, 2018
Substituted pyridazines as prostacyclin receptor modulators
ARENA PHARM INC1 citations60
USRE50267EJan 14, 2025
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations59
TEEGARDEN BRADLEY
2 patentsUS8664258B2Mar 4, 2014
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY14 citations91
US8148417B2Apr 3, 2012
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY21 citations91